An evaluation of US patent 2015065565 (A1) for a new class of SGLT2 inhibitors for treatment 1 of type II diabetes mellitus

Meiyan Jiang, Peter S. Steyger

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'An evaluation of US patent 2015065565 (A1) for a new class of SGLT2 inhibitors for treatment 1 of type II diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds